Off-the-shelf stem cell therapy for type 1 diabetes yields more positive results
statnews.com · 204 words · saved by 1 readers
An off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results, according to a new study.
Twelve people with type 1 diabetes who received an investigational off-the-shelf stem cell therapy were able to produce their own insulin and keep healthy blood glucose levels for at least one year, Vertex Pharmaceuticals said Friday. After three months, none of them suffered severe bouts of low blood sugar. After 12 months, out of the 12 participants, 10 no longer needed to inject insulin. The study, presented Friday at the American Diabetes Association’s scientific meeting and simultaneously published in the New England Journal of Medicine, updates previous research that followed these…
saved by
related reading
- Chinese Scientists Transplant Stem Cell-derived Islets to Treat Type 1 Diabetesenglish.cas.cn
- Scientists track cellular disruptions that lead to type 1 diabetesstatnews.com
- I’m using not-FDA-approved software to manage my diabetes. I’ve never felt betterstatnews.com
- Stem cells reverse woman’s diabetes — a world firstnature.com
- A Potential Dramatic Change in Treating Type 1 Diabetes - Jacobs School of Medicine and Biomedical Sciences - University at Buffalomedicine.buffalo.edu
- Sanofi Tzield: The 200 Best Inventions of 2023 | TIMEtime.com
- Why Does Ozempic Cure All Diseases?astralcodexten.com
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease | Scientific Americanscientificamerican.com
- Weekly Dose of Optimism #96notboring.co
- For the First Time, a Cell Built From Scratch Grows and Divides | Quanta Magazinequantamagazine.org
- World-first: therapy to make cells young again trialled in a personnature.com